Stay updated with breaking news from Binfeng Lu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
According to a recent study published on November 24th, 2022 in the journal Nature Nanotechnology, scientists at the University of Pittsburgh have created cancer-fighting nanoparticles that deliver both a novel immunotherapy and a chemotherapy drug.
University of Pittsburgh researchers have designed cancer-fighting nanoparticles that co-deliver a chemotherapy drug and a novel immunotherapy, according to a new Nature Nanotechnology study published today.
“Tissue Alarmin Cytokines as a Novel Cancer Immunotherapy” Presented by: Binfeng Lu, PhD Director, Center for Discovery and Innovation of Hackensack Meridian Health Member, Georgetown Lombardi Cancer-Host Interactions Program Location: Join remotely via Zoom Sponsor: Michael Atkins, MD Lecture Series Presented by Georgetown Lombardi Comprehensive Cancer Center